Background
QuickMed Diagnostic sued Aetna Health and Life Insurance Company and related entities over allegedly unpaid or underpaid claims for COVID-19 diagnostic testing. QuickMed says patients assigned it their health-plan benefits, allowing it to seek payment directly from plans governed by the Employee Retirement Income Security Act (ERISA), the federal law regulating most private employee benefit plans.
The complaint also asserted fiduciary-duty, federal COVID-relief-statute, Medicare, and California-law theories. The court treated the dispute consistently with a related lead case involving another insurer and evaluated which claims were adequately pleaded and which were displaced by federal benefit-plan law.
The Court’s Holding
The court allowed QuickMed’s core ERISA claim for benefits to proceed. It held that the alleged patient assignments were sufficiently definite at the pleading stage, rejecting Aetna’s argument that QuickMed lacked standing to pursue assigned benefits. The request for declaratory relief also survived.
Other theories did not. The court dismissed the fiduciary-duty claim with leave to amend, dismissed the claim under the Families First Coronavirus Response Act and CARES Act without leave to amend, and dismissed Medicare theories with leave to amend because QuickMed had not alleged exhaustion of the required administrative process. California-law claims were dismissed with leave to amend because ERISA may preempt state claims that duplicate or depend on plan-benefit obligations.
Key Takeaways
- A healthcare provider may plead derivative ERISA standing by alleging a sufficiently definite assignment of benefits from patients.
- A benefits-recovery claim can survive even when broader fiduciary-duty theories are inadequately pleaded.
- Medicare reimbursement claims generally require exhaustion of administrative remedies before federal-court review.
- State contract or reimbursement theories face ERISA preemption when their viability turns on rights created by an employee benefit plan.
- The federal COVID-testing statutes did not provide QuickMed a viable standalone claim on the allegations presented.
Why It Matters
California diagnostic providers pursuing pandemic-era reimbursement should separate a concrete assigned-benefits theory from alternative statutory and state-law claims. Insurers, meanwhile, should not assume that an assignment challenge will defeat a provider’s case at the pleading stage when the complaint describes an actual transfer of benefit rights.
The order also underscores the importance of claim-by-claim exhaustion and preemption analysis. Providers should document assignments and administrative appeals before filing, while plan defendants should identify exactly how each state claim relates to plan administration rather than treating ERISA preemption as automatic.
Read the full opinion (PDF) · Court docket